Immunotherapy for congenital cytomegalovirus infection.

1402 n engl j med 353;13 www.nejm.org september 29, 2005 7. Fioretti P, Benussi B, Scardi S, Klugmann S, Brower RW, Camerini F. Afterload reduction with nifedipine in aortic insufficiency. Am J Cardiol 1982;49:1728-32. 8. Scognamiglio R, Rahimtoola SH, Fasoli G, Nistri S, Dalla Volta S. Nifedipine in asymptomatic patients with severe aortic regurgitation and normal left ventricular function. N Engl J Med 1994;331: 689-94. 9. Scognamiglio R, Negut CH, Palisi M, Fasoli G, Dalla-Volta S. Long-term survival and functional results after aortic valve replacement in asymptomatic patients with chronic severe aortic regurgitation and left ventricular dysfunction. J Am Coll Cardiol 2005;45: 1025-30. 10. Evangelista A, Tornos P, Sambola A, Permanyer-Miralda G, SolerSoler J. Long-term vasodilator therapy in patients with severe aortic regurgitation. N Engl J Med 2005;353:1342-9. 11. Scognamiglio R, Fasoli G, Ponchia A, Dalla-Volta S. Long-term nifedipine unloading therapy in asymptomatic patients with chronic severe aortic regurgitation. J Am Coll Cardiol 1990;16:424-9. 12. Kloner RA, Birnbaum Y, eds. Cardiovascular trials review. 9th ed. Darien, Conn.: Le Jacq, 2004. 13. ACC/AHA guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). J Am Coll Cardiol 1998;32:1486-588. Copyright © 2005 Massachusetts Medical Society.